As a clinician, educator, and emotion researcher, I have long believed that our efforts to optimise the wellbeing of health-care professionals are doomed if we cannot talk openly about the emotional ...
9h
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
Babelsberg Palace in Potsdam is a UNESCO World Heritage Site. Once the summer residence of Emperor William I, it is now a ...
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
Hemorrhage—severe heavy bleeding—and hypertensive disorders like preeclampsia are the leading causes of maternal deaths ...
6d
MedPage Today on MSNCDC Plans Large Study on Autism and Vaccines, Report SaysThe CDC is planning a large study looking into potential connections between vaccines and autism, two sources told Reuters, ...
Rabies is a deadly disease that spreads through animal bites, mostly from dogs. Experts warn that just getting a vaccine may ...
A study in the Lancet has found that 60 per cent of adults and a third of children and teens will be living with overweight ...
The study, published in The Lancet Global Health, marks WHO’s first comprehensive update on maternal mortality causes since ...
5d
News-Medical.Net on MSNWHO study sheds light on global maternal mortality crisisHemorrhage – severe heavy bleeding – and hypertensive disorders like preeclampsia are the leading causes of maternal deaths globally, according to a new study released today by the World Health ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results